| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology and Critical Care Medicine, HadassahHebrew University School of Medicine, Jerusalem, Israel
Address correspondence and reprint requests to Charles Weissman, MD, Department of Anesthesiology and Critical Care Medicine, HadassahUniversity Hospital, Kiryat Hadassah, POB 12000, Jerusalem, Israel 91120. Address e-mail to Charles @hadassah.org.il.
| Introduction |
|---|
|
|
|---|
| Perioperative Respiratory Function: A Brief Overview |
|---|
|
|
|---|
| Preoperative Pulmonary Function Testing |
|---|
|
|
|---|
The exception to these recommendations are patients undergoing lung resection, in which spirometry and arterial blood gas tension determinations are essential for predicting postresection lung function (4). When there is doubt about the predicted amount of residual postresection function, patients may require further assessment with diffusing capacity, right heart catheterization with temporary unilateral pulmonary artery occlusion, cardiopulmonary exercise testing, quantitative computed tomographic (CT) scanning, or radionuclide quantitative ventilation-perfusion scanning (5,6).
| Cardiac Surgery |
|---|
|
|
|---|
The major determinant of poor pulmonary outcome after cardiac surgery is poor cardiac function (3). This is not unanticipated, because a low cardiac output state directly and indirectly contributes to varying pulmonary problems. A low cardiac output with increased pulmonary capillary wedge pressure results in increased lung water. Depending on its severity, a spectrum of problems from mild congestive heart failure to overt cardiogenic pulmonary edema may occur (Figure 1). Moreover, the low cardiac output state results in muscle fatigue, leading to weak coughing, reduced mobility, and lack of deep breathing. These may contribute to and worsen atelectasis and increase the possibility of pneumonia.
|
|
Median sternotomy alters the spinocostal angles, thus reducing the mobility of the ribs (14). These structural changes, along with incisional pain, may contribute to a breathing pattern characterized by small tidal volumes and increased respiratory rates. The degree of postoperative diaphragmatic dysfunction is unclear, although elevated diaphragms are seen on chest radiographs in
13% of patients after surgery. Clergue et al. (15) speculated that these diaphragmatic elevations might be due not only to atelectasis, but also to diaphragmatic dysfunction caused by either phrenic nerve damage or reflex-mediated decreases in diaphragmatic function.
Phrenic nerve injury most often occurs on the left side, and it is almost always caused by irrigating the pericardial space with cold solution for myocardial preservation during CPB. Electrophysiological evidence of nerve injury is seen in 32% of patients when ice slush is used and in 2%6% when cold saline is used (16). The prevalence of clinically significant diaphragmatic dysfunction is 2.1% when the heart is cooled without an insulation pad protecting the phrenic nerve and approximately 0.5% without any topical cooling (17). It is rarely seen when only intracoronary cardioplegia is used (18). Although it is often short-lived, diaphragmatic dysfunction may interfere with discontinuation of mechanical ventilation. Unfortunately, in some patients, the dysfunction may persist for
6 mo and interfere with activities of daily living. Rarely, phrenic injury may occur during internal mammary artery harvesting because the nerve crosses the path of the artery on the left side and the two run in parallel on the right side (19).
Despite the high rate of radiographic atelectasis, the incidence of clinically significant pulmonary complications after cardiac surgery is relatively low (7). This is likely due to early mobilization and pain control. This low incidence and low morbidity of pulmonary complications are reflected by the inability of a randomized study to identify any advantage of adding single-handed percussions to early mobilization and deep breathing exercises after valvular surgery (7). Similarly, routine physical therapy does not benefit patients after elective coronary artery surgery (20).
There are less common causes of postcardiac surgery respiratory failure. Noncardiogenic pulmonary edema has long been of concern because early CPB techniques were associated with postoperative hypoxemia and noncardiogenic pulmonary edemapostpump lung. Yet, the incidence of this complication has decreased likely because of changes in techniques, such as the introduction of membrane oxygenators. This was demonstrated by a recent study, which revealed that adult respiratory distress syndrome occurred in only 1% (38 of 3848) of patients after coronary artery bypass and valve replacement surgery (21). Changes in clinical management have altered the pattern of postoperative complications so that supraventricular arrhythmias (incidence 17%20%), not serious pulmonary problems, are now the leading cause of postcardiac surgery morbidity (22).
There are a number of causes of hypoxemia after cardiac surgery. The incidence of severe hypoxemia (PaO2
150 mm Hg) was found by Rady et al. (23) to be 12% in a group of patients without preexisting pulmonary hypertension or obstructive or restrictive lung disease undergoing coronary bypass and valve replacement. Such patients have a higher mortality rate and longer hospital stay. Risk factors for severe hypoxemia include age >75 yr, body mass index >30 kg/m2, mean pulmonary artery pressure >20 mm Hg, reduced stroke volume, decreased serum albumin, a history of cerebrovascular disease, emergency surgery, and extended bypass time (23). The amount of bilateral dependent atelectasis seen on CT scans correlates with the degree of venous admixture (24). The hypoxemia is mainly due to increased shunt fraction, although low mixed venous PO2 secondary to reduced cardiac output also is a contributing factor (24). As expected, patients with left lower lobe atelectasis have lower arterial oxygen tension when placed in the left lateral decubitus position. In a subsequent study, no differences were found between intra- and postoperative intrapulmonary shunt and ventilation-perfusion relationships when patients undergoing coronary bypass and mitral valve replacement were compared. This does not support the hypothesis that patients with mitral valve disease have more intrapulmonary shunting after surgery due to residual lung water from chronically increased preoperative lung water (25).
Zin et al. (26) observed that, before surgery, patients with valvular heart disease had increased lung and respiratory elastances and lung resistance than patients with ischemic disease, probably because of the higher incidence of left ventricular failure in the former group. These differences decreased postoperatively. Long-term respiratory outcome after valve surgery is favorable, as pulmonary function actually improves after surgery. However, after mitral valve surgery, FVC, FEV1, and MVV are all reduced below preoperative levels on discharge from the hospital, and after 3 mo, all increased above preoperative levels, but remained below predicted values (27).
Fast-Tracking
The increasing popularity of early postoperative extubation has confirmed the advantages of allowing patients to cough and ambulate soon after surgery. A retrospective matched cohort study demonstrated that patients tracheally extubated early after surgery have significantly less atelectasis than those extubated later. Additionally, on Postoperative Day 5, vital capacity (VC) and FEV1/FVC were increased after early extubation (28). Fast-tracking is also associated with significantly lower rates of nosocomial pneumonia. In one study, 3.4% of patients <70 yr old and 4.4% of those >70 yr developed pneumonia (29).
Minimally Invasive Cardiac Surgery
Minimally invasive cardiac surgery performed through a limited thoracotomy or thorascopically, at times without CPB, has recently been introduced. In a preliminary report, Chitwood et al. (30) reported no cases of pneumonia after video-assisted mitral valve surgery and three cases after sternotomy. After port-access coronary artery bypass with a left mammary artery graft, 3 of 42 patients had pleural effusions and 2 had left lower lobe atelectasis. No prospective randomized study has compared the incidence of pulmonary complications after minimally invasive cardiac surgery with that after sternotomy.
Pain Management
After cardiac surgery, patients have significant thoracic pain, and patients who underwent coronary artery bypass also have pain in the area of the venous graft harvest. However, it is not surprising that the pain is less than that after upper abdominal surgery and lateral thoracotomy, because median sternotomy does not entail dividing muscles (Table 2). Once the effects of anesthesia dissipate, IV opioids are used most commonly. Until extubation, this tends to be nurse-administered IV morphine, and after extubation, nurse-administered or patient-controlled analgesia are used. Within a day or two, many patients require only oral analgesics, such as oxycodone plus acetaminophen. Yet, several studies have shown that pain relief is often inadequate, a situation especially problematic when early extubation is planned (31).
|
| Thoracic Surgery |
|---|
|
|
|---|
The effect of thoracotomy on respiratory patterns and muscle function remains unclear. Reduced motion of the chest wall is predictable because of muscle injury and spasm, as well as pain. However, posterolateral thoracotomy does not change the relative contributions of the chest wall and abdomen to tidal volume (40). The lack of an effect on chest wall motion is not immediately apparent but could be due to pain relief restoring a normal respiratory pattern, the fact that most thoracotomy incisions are posterior and splinted by the scapula, or diaphragmatic dysfunction caused by supradiaphragmatic stimulation necessitating compensatory chest wall motion. Maeda et al. (41) observed an increase in respiratory rate, but not tidal volume, after thoracotomy. During quiet breathing, there were suggestions of preserved diaphragmatic function but evidence of increased intercostal/accessory muscle function likely due to expiratory activity of the abdominal muscles or resistance to lung inflation. At maximal inspiration, there were suggestions of reduced maximal diaphragmatic strength. Similarly, after pneumonectomy, transdiaphragmatic pressure seems to be preserved (42). Using sonomicrometry crystals in sheep, Torres et al. (43) found that diaphragmatic shortening was depressed for at least 4 wk after thoracotomy. Human studies showed decreased shortening of the costal portion of the diaphragm, which is unaffected by lidocaine epidural anesthesia. However, the epidural medication is associated with greater tidal volumes, VCs, and transdiaphragmatic pressures (44). It seems that surgery above the diaphragm reduces diaphragmatic function, although not to the same degree as upper abdominal surgery.
Pulmonary complications are still a major cause of morbidity after thoracotomy. In a prospective observational study, Amar et al. (45) reported that respiratory failure developed in 3 of 47 postlobectomy and 3 of 39 postpneumonectomy patients. Pneumonia was observed in three lobectomies and no pneumonectomies. In a report on 7099 thoracic procedures performed in Japan, there was a 1.3% 30-day mortality rate (3.2% after pneumonectomies, 1.2% after lobectomies). Forty-eight deaths were due to pneumonia and respiratory failure, and five were due to bronchopleural fistulae and empyema (46).
Alternative Incisions
The traditional posterolateral thoracotomy involves a long muscle-splitting incision that results in pain and muscle stiffness after surgery. Surgeons have developed approaches, such as limited thoracotomies, axillary thoracotomies, and muscle-sparing incisions to decrease this discomfort. Limited thoracotomies cause less reduction in respiratory muscle strength and FVC than standard thoracotomies. Using a nonseratus-sparing anterioaxillary thoracotomy with disconnection of the anterior rib cartilage causes less of a reduction in FEV1 and VC 1 wk after surgery than posterolateral thoracotomy (47). Despite the differences in pulmonary function, there are no differences in either short- or long-term pulmonary or other morbidity between the two incisions.
Thoracoscopy
Video-assisted thoracoscopy with two or three stab incisions further reduces postoperative discomfort and attenuates postoperative reductions in pulmonary function. This is confirmed by the findings that thoracoscopy causes less pain, decreases opioid requirements and results in lesser reductions in respiratory muscle strength and lung volumes compared with posterolateral thoracotomy (48). When thorascopic lobectomies are compared with those performed through muscle-sparing incisions, there are no differences in postoperative pulmonary function, although there is less pain. This is not unexpected because similar amounts of lung tissue are removed; however, these findings reduce the strength of the claim that postoperative pain plays an important role in reducing postoperative pulmonary function. Similarly, in sheep, the diaphragmatic shortening fraction recovers slightly faster after thoracoscopy, but this does not translate into a functional advantage compared with lateral thoracotomy (49).
Long-Term Consequences
Long-term consequences of pulmonary resection include the effects of reduced lung tissue. FEV1 and FVC are reduced immediately after surgery due to the removal of lung tissue, pain, and atelectasis. Over the next 6 mo, there is slow improvement in pulmonary function after lobectomy, but not pneumonectomy. FEV1, VC, and total lung capacity increase as atelectatic areas re-expand and as ventilation-perfusion relations improve. Exercise capacity 6 mo after lobectomy is unchanged from preoperative capacity in most patients, whereas it is reduced by 20% after pneumonectomy. Similar findings are observed 12 mo after pulmonary resection (50).
Pain Management
Posterolateral thoracotomy is reported to be among the most painful of surgical incisions because major muscles are transected and rib(s) are removed (Table 2). Additionally, chest tube insertion sites are often very painful. Ameliorating this pain is essential for patient comfort and to facilitate coughing and maneuvers designed to prevent atelectasis, such as deep breathing exercises and incentive spirometry.
The salutary effects of contemporary postoperative pain management techniques after thoracotomy remain unproven. Specifically, the ability of superior analgesia to decrease the incidence of pulmonary complications must be balanced against the respiratory depressive effects of opioids. The most frequently used analgesic modality is continuous epidural infusion of opioids and local anesthetic via a midthoracic level catheter (51). Some (52), but not all (53), studies have reported that epidural opioids are superior to IV opioids in attenuating postoperative reductions in lung volume. However, these studies involved small numbers of patients and focused on analgesia scores and immediate side effects with respiratory measurements limited to spirometry and blood gas analysis. No large randomized study has yet examined whether epidural analgesia reduces complications and improves outcome after thoracotomy. A meta-analysis that included both postabdominal and postthoracotomy patients concluded that, compared with systemic opioids, epidural opioids reduce the incidence of atelectasis, pulmonary infections, and pulmonary complications (54). Additionally, patients who received epidural local anesthetics had reduced incidences of pulmonary complications compared with systemic opioids.
The epidural administration of opioids after thoracotomy presents a particular challenge because of the need to deliver medication to the upper thoracic region without causing respiratory compromise. Initial studies found significant PaCO2 elevations (>50 mm Hg) when 5 mg and 0.15 mg/kg morphine were injected into the lumbar epidural space. This led to the recommendation that the dose of lumbar epidural morphine be reduced to 2.53.0 mg. Subsequent observations with these smaller doses found that the possibility of respiratory depression with epidural opioids is always present, but the incidence is low. Only 0.6% of 504 postthoracotomy patients receiving epidural analgesia with bupivacaine plus fentanyl or morphine have respiratory rates <10 bpm (55). Other investigators have found the incidence to be <0.1% (56).
Epidural analgesic regimens using mixtures of local anesthetics and opioids are currently popular. Whether such mixtures result in less respiratory depression is unclear, although they do decrease the incidence of hypotension. In postthoracotomy patients, adding bupivacaine to a thoracic epidural fentanyl infusion does not alter the degree of reduction in FVC, FEV1, or PEFR, but it reduces the PaCO2 (57). Similarly, adding epidural morphine to a continuous infusion of thoracic epidural bupivacaine does not influence PEFR, FEV1, or FVC, nor is there a difference in the suppression of the ventilatory response to CO2 between sufentanil alone and in combination with bupivacaine. However, recovery after stopping the infusion is faster in the combination group (58).
Nonsteroidal antiinflammatory drugs, especially ketorolac tromethamine, are used to supplement opioid analgesia. These drugs work synergistically with opioids and have no respiratory depressive effects. Disadvantages include platelet dysfunction and renal dysfunction. IV ketorolac is a better supplement for patient-controlled epidural hydromorphone analgesia than adding bupivacaine (59). Ketorolac is also more effective (requires less on-demand opioid administration) than extrapleural intercostal nerve blocks with intermittent bupivacaine (60).
Current analgesic practice includes using epidural opioids with or without local anesthetics, supplemented with nonsteroidal antiinflammatory drugs. Although these regimens provide excellent pain relief, it is still unclear whether they reduce pulmonary morbidity.
| Esophagectomy |
|---|
|
|
|---|
Patients are often mechanically ventilated after esophagogastrectomy. The introduction of epidural analgesia has facilitated early extubation either immediately or soon after the completion of surgery. In patients who receive 2 mg of epidural morphine both at T67 and at T34 at the time of incision, the addition of a continuous epidural infusion of 0.25% bupivacaine (at 3 mL/h) results in earlier extubation (4.4 vs 13.7 h) than when isotonic sodium chloride solution is infused (62). Early extubation after esophagectomy is associated with reduced morbidity and decreased length of ICU stay (63).
Some investigators have credited superior analgesia with improving outcome after esophagogastrectomy. Patients given either epidural, patient-controlled analgesic, or continuous IV morphine have fewer (13% vs 25%) respiratory complications, shorter hospital stays, and fewer (21% vs 43%) cardiovascular complications, as well as lower mortality (8% vs 14%), than those given intramuscular meperidine (64). Similar reductions in hospital stay have been reported among patients who receive epidural rather than IV morphine (65).
| Conclusions |
|---|
|
|
|---|
Pain management has long been considered part of the defense against postoperative atelectasis and pneumonia. Yet the evidence is sparse and disappointing because most studies involve small numbers of patients and focus on analgesia scores and immediate side effects. Only a few investigations have examined outcome. Interestingly, there is more evidence that epidural and other advanced pain modalities may reduce morbidity after esophagectomy than after lobectomy or cardiac surgery. The impression based on available evidence is that opioid analgesia, even when administered in novel ways, has only a limited ability to reduce or attenuate the postoperative alterations in pulmonary function and may even contribute to pulmonary complications by causing respiratory depression. If this is true, then more analgesics that do not depress respiration, e.g. nonsteroidal antiinflammatory drugs, should be used in this setting.
There is limited evidence regarding whether the newer approaches to pain management are truly cost-effective. The cost-benefit (reduced length of hospital stay, earlier recovery of gastrointestinal function) of superior pain relief has been demonstrated in colonic surgery (66), and similar studies are needed in cardiac and thoracotomy patients.
It is also currently unknown whether analgesia improves coughing effectiveness and facilitates the treatment and prophylaxis of atelectasis and pneumonia with incentive spirometry and deep breathing exercises. The future challenge will be to evaluate the efficacy of current practices while simultaneously devising new methods that reduce complications and improve outcome.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
O. Levionnois and P. Kronen Development of post-pump syndrome in a sheep after mitral valve stenting Lab Anim, October 1, 2008; 42(4): 505 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Tenenbein, R. Debrouwere, D. Maguire, P. C. Duke, B. Muirhead, J. Enns, M. Meyers, K. Wolfe, and S. E. Kowalski Thoracic epidural analgesia improves pulmonary function in patients undergoing cardiac surgery: L'analgesie peridurale thoracique ameliore la fonction pulmonaire chez les patients subissant une chirurgie cardiaque Can J Anesth, June 1, 2008; 55(6): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Hulzebos, N. L. van Meeteren, B. J. van den Buijs, R. A de Bie, A B. de la Riviere, and P. J. Helders Feasibility of preoperative inspiratory muscle training in patients undergoing coronary artery bypass surgery with a high risk of postoperative pulmonary complications: a randomized controlled pilot study Clinical Rehabilitation, November 1, 2006; 20(11): 949 - 959. [Abstract] [PDF] |
||||
![]() |
P. Lahtinen, H. Kokki, T. Hakala, and M. Hynynen S(+)-Ketamine as an Analgesic Adjunct Reduces Opioid Consumption After Cardiac Surgery Anesth. Analg., November 1, 2004; 99(5): 1295 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ott, N. A. Nussmeier, P. C. Duke, R. O. Feneck, R. P. Alston, M. C. Snabes, R. C. Hubbard, P. H. Hsu, L. J. Saidman, and D. T. Mangano Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1481 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lena, N. Balarac, J. J. Arnulf, J. Teboul, and F. Bonnet Intrathecal morphine and clonidine for coronary artery bypass grafting Br. J. Anaesth., March 1, 2003; 90(3): 300 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amini, A. Gabrielli, L. J. Caruso, and A. J. Layon The Thoracic Surgical Patient: Initial Postoperative Care Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 169 - 188. [Abstract] [PDF] |
||||
![]() |
M. Capdeville and J. H. Lee Off-Pump Coronary Artery Bypass Surgery: Revival of an Old Technique Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 345 - 361. [Abstract] [PDF] |
||||
![]() |
H. J. Skinner, K. J. West, M. Jasinski, and T. J. Spyt Cardiac surgery in octogenarians with poor lung function. Ann. Thorac. Surg., June 1, 2001; 71(6): 2084 - 2085. [Full Text] [PDF] |
||||
![]() |
F. W Dupont Anesthesia for Esophageal Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2000; 4(1): 2 - 17. [Abstract] [PDF] |
||||
![]() |
H. Yukioka Earlier extubation after esophagectomy is successfully performed with thoracic epidural bupivacaine combined with thoracic and lumbar epidural morphine. Anesth. Analg., December 1, 1999; 89(6): 1592 - 1592. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||